Bank Of Montreal Intercept Pharmaceuticals, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Jun 13, 2024	BUY	$12.53 - $21.71 $145,222 - $251,618	11,590 New	11,590 $155,000
Q2 2022 Aug 11, 2022	BUY	$11.23 - $19.59 $259,806 - $453,214	23,135 New	23,135 $315,000
Q4 2021 Feb 11, 2022	SELL	$14.28 - $19.53 $877,577 - $1.2 Million	-61,455 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$12.99 - $20.47 $89,137 - $140,465	-6,862 Reduced 10.04%	61,455 $959,000
Q2 2021 Aug 12, 2021	BUY	$15.46 - $24.5 $1.06 Million - $1.67 Million	68,317 New	68,317 $1.46 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.